[Evaluation of absorbent sheet to prevent anticancer drugs contamination spread in urine].


Journal

Sangyo eiseigaku zasshi = Journal of occupational health
ISSN: 1349-533X
Titre abrégé: Sangyo Eiseigaku Zasshi
Pays: Japan
ID NLM: 9507473

Informations de publication

Date de publication:
25 May 2023
Historique:
medline: 26 5 2023
pubmed: 8 8 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Medically, anticancer drugs contamination leading to human exposure has become an issue. The urine of patients receiving chemotherapy contains anticancer drugs. If urine containing anticancer drugs is excreted, the anticancer drugs are scattered around the toilet bowl, then adhere to slipper soles and spread. Therefore, we developed an absorbent sheet containing activated carbon that absorbs anticancer drugs and prevents anticancer drug contamination spread. In this article, we report the data on the sheet performance evaluation. In artificial urine solutions, 100 μL (20 drops) of cyclophosphamide (CPA; 2,000 μg/mL), methotrexate (MTX; 6,000 μg/mL), and paclitaxel (PTX; 200 μg/mL) were dropped onto the stainless plate of two commercially available medical sheets (Pitapa Sheet An average of 31.5%, 38.7%, and 50.5% of each of the dropped anticancer agents (CPA, MTX, and PTX, respectively) adhered to the slipper sole. Compared to that of the control product 2, the average adhesion of CPA and MTX was significantly reduced in the test product containing activated charcoal (224 vs 2 μg, p < .050 and 2,235 vs 19 μg, p < .050). Contrastingly, there was no significant difference in the PTX mean adherence (35 vs 13 μg). Activated carbon adsorbs anticancer drugs in urine. The test product containing activated charcoal reduced the amount of scattered anticancer drugs that adhered to the slippers. The results suggest that the activated carbon sheet may prevent anticancer drugs contamination spread in urine.

Identifiants

pubmed: 35934794
doi: 10.1539/sangyoeisei.2022-006-B
doi:

Substances chimiques

Charcoal 16291-96-6
Antineoplastic Agents 0
Methotrexate YL5FZ2Y5U1
Cyclophosphamide 8N3DW7272P

Types de publication

English Abstract Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

134-141

Auteurs

Junya Sato (J)

Department of Pharmacy, International University of Health and Welfare Hospital.
School of Pharmacy, International University of Health and Welfare.

Makoto Yokoi (M)

FUTAMURA CHEMICAL CO., LTD.

Sayaka Hori (S)

FUTAMURA CHEMICAL CO., LTD.

Yasunori Hotta (Y)

FUTAMURA CHEMICAL CO., LTD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH